Jane Street’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.8M Buy
202,400
+67,900
+50% +$14.6M 0.01% 1162
2025
Q4
$27.6M Sell
134,500
-61,500
-31% -$11.6M ﹤0.01% 1333
2025
Q3
$30.8M Sell
196,000
-88,000
-31% -$13.6M ﹤0.01% 1275
2025
Q2
$47.7M Buy
284,000
+27,500
+11% +$4.08M 0.01% 790
2025
Q1
$35.3M Buy
256,500
+61,400
+31% +$7.83M 0.01% 881
2024
Q4
$23.1M Sell
195,100
-85,300
-30% -$9.96M 0.01% 1161
2024
Q3
$31M Sell
280,400
-26,000
-8% -$2.72M 0.01% 958
2024
Q2
$30.1M Buy
306,400
+117,000
+62% +$11.9M 0.01% 977
2024
Q1
$21.2M Sell
189,400
-181,100
-49% -$19.5M ﹤0.01% 1140
2023
Q4
$37.3M Buy
370,500
+296,400
+400% +$29.4M 0.01% 838
2023
Q3
$6.43M Sell
74,100
-4,000
-5% -$362K ﹤0.01% 2284
2023
Q2
$7.39M Buy
78,100
+47,300
+154% +$4M ﹤0.01% 2241
2023
Q1
$2.33M Sell
30,800
-144,400
-82% -$10.9M ﹤0.01% 3559
2022
Q4
$13.5M Sell
175,200
-128,800
-42% -$9.79M 0.01% 1330
2022
Q3
$20.3M Buy
304,000
+58,600
+24% +$3.71M 0.01% 1058
2022
Q2
$12.8M Buy
245,400
+7,200
+3% +$409K 0.01% 1480
2022
Q1
$13.5M Buy
238,200
+6,000
+3% +$321K ﹤0.01% 1630
2021
Q4
$12M Buy
232,200
+42,100
+22% +$2.06M ﹤0.01% 1680
2021
Q3
$9.4M Buy
190,100
+100
+0.1% +$5.42K ﹤0.01% 1877
2021
Q2
$10.8M Buy
190,000
+118,700
+166% +$6.94M ﹤0.01% 1623
2021
Q1
$4.33M Buy
71,300
+600
+0.8% +$33.1K ﹤0.01% 2615
2020
Q4
$3.79M Sell
70,700
-69,900
-50% -$3.63M ﹤0.01% 2492
2020
Q3
$6.6M Sell
140,600
-32,500
-19% -$1.67M ﹤0.01% 1575
2020
Q2
$9.03M Buy
173,100
+127,000
+275% +$6.55M 0.01% 1266
2020
Q1
$2.21M Buy
46,100
+23,800
+107% +$1.24M ﹤0.01% 1925
2019
Q4
$1.13M Buy
22,300
+8,900
+66% +$460K ﹤0.01% 2600
2019
Q3
$632K Sell
13,400
-3,600
-21% -$164K ﹤0.01% 3227
2019
Q2
$801K Buy
17,000
+9,100
+115% +$420K ﹤0.01% 2985
2019
Q1
$380K Sell
7,900
-13,600
-63% -$681K ﹤0.01% 3995
2018
Q4
$959K Buy
+21,500
New +$1.12M ﹤0.01% 2624
2018
Q3
Sell
-5,900
Closed -$288K 5107
2018
Q2
$288K Buy
5,900
+1,400
+31% +$79.4K ﹤0.01% 4161
2018
Q1
$282K Sell
4,500
-2,500
-36% -$172K ﹤0.01% 4092
2017
Q4
$429K Sell
7,000
-12,700
-64% -$785K ﹤0.01% 3358
2017
Q3
$1.32M Buy
19,700
+15,000
+319% +$1.06M ﹤0.01% 2011
2017
Q2
$366K Sell
4,700
-1,300
-22% -$98.1K ﹤0.01% 3386
2017
Q1
$489K Sell
6,000
-21,100
-78% -$1.66M ﹤0.01% 2905
2016
Q4
$1.95M Buy
27,100
+18,100
+201% +$1.31M 0.01% 1346
2016
Q3
$699K Buy
9,000
+5,400
+150% +$436K ﹤0.01% 2394
2016
Q2
$281K Sell
3,600
-1,300
-27% -$104K ﹤0.01% 3397
2016
Q1
$402K Sell
4,900
-600
-11% -$48.8K ﹤0.01% 2838
2015
Q4
$491K Buy
+5,500
New +$467K ﹤0.01% 2509
2015
Q3
Sell
-6,200
Closed -$519K 3592
2015
Q2
$519K Buy
6,200
+3,400
+121% +$300K ﹤0.01% 2251
2015
Q1
$253K Buy
+2,800
New +$241K ﹤0.01% 2675

Other funds holding CAH

Jane Street's CAH Position: Q1 2026 in Review

Jane Street reduced its Cardinal Health (CAH) stake by 96% in Q1 2026, selling an estimated $93.4M and leaving 18,369 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3910.

Jane Street first reported a position in CAH in Q4 2013 and has held it in 46 quarters since. The position peaked at $92.9M in Q4 2025. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Jane Street held 18,369 shares of Cardinal Health worth $3.88M as of Q1 2026.
  • Jane Street sold 433,810 Cardinal Health shares in Q1 2026, an estimated $93.4M.
  • Cardinal Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3910 holding.
  • Jane Street first reported a position in Cardinal Health in Q4 2013 and has held it in 46 quarters since.
  • Jane Street's Cardinal Health position peaked at $92.9M in Q4 2025.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.